Becton Dickinson agreed to acquire an Edwards Lifesciences unit for $4.2 billion in cash, putting it near the top of its many M&A deals.
Becton Dickinson agreed to acquire an Edwards Lifesciences unit for $4.2 billion in cash, putting it near the top of its many M&A deals.